BioTricity Inc. Files 8-K on Security Holder Vote Matters
Ticker: BTCY · Form: 8-K · Filed: Aug 16, 2024 · CIK: 1630113
Sentiment: neutral
Topics: 8-K, corporate-governance, shareholder-vote
TL;DR
BioTricity Inc. filed an 8-K for a security holder vote. Details TBD.
AI Summary
BioTricity Inc. filed an 8-K on August 16, 2024, reporting on matters submitted to a vote of its security holders as of August 15, 2024. The filing does not contain specific details about the vote outcomes or the proposals presented.
Why It Matters
This filing indicates that BioTricity Inc. held a vote of its security holders, which could pertain to significant corporate actions or governance changes.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose specific financial or operational risks at this time.
Key Players & Entities
- BIOTRICITY INC. (company) — Registrant
- August 15, 2024 (date) — Date of earliest event reported
- August 16, 2024 (date) — Date of report
- Nevada (jurisdiction) — State of Incorporation
- 203 Redwood Shores Parkway, Suite 600 (address) — Principal Executive Offices
- Redwood City, California (location) — Principal Executive Offices City and State
FAQ
What specific matters were submitted to a vote of BioTricity Inc.'s security holders?
The filing does not specify the exact matters submitted for a vote, only that such matters were reported on.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on August 15, 2024.
What is the principal executive office address for BioTricity Inc.?
The principal executive office is located at 203 Redwood Shores Parkway, Suite 600, Redwood City, California 94065.
In which state is BioTricity Inc. incorporated?
BioTricity Inc. is incorporated in Nevada.
What is the filing date of this 8-K report?
The report was filed on August 16, 2024.
Filing Stats: 552 words · 2 min read · ~2 pages · Grade level 13.1 · Accepted 2024-08-16 17:01:57
Key Financial Figures
- $0.001 B — ch registered Common Stock, Par Value $0.001 BTCY Nasdaq Capital Market Indicate
- $6,600,000 — oposal to approve the issuance of up to $6,600,000 of the Company's common stock upon the
Filing Documents
- form8-k.htm (8-K) — 46KB
- 0001493152-24-032861.txt ( ) — 216KB
- btcy-20240815.xsd (EX-101.SCH) — 3KB
- btcy-20240815_lab.xml (EX-101.LAB) — 33KB
- btcy-20240815_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: August 16, 2024 BIOTRICITY INC. By: /s/ Waqaas Al-Siddiq Waqaas Al-Siddiq Chief Executive Officer